Article
Structural basis for the unexpected activity of rifamycin B against rifampicin-resistant RNA polymerase
2026-07-14
Abstract excerpt
<h4>Summary</h4> Rifamycins inhibit bacterial transcription by targeting RNA polymerase (RNAP), but their clinical effectiveness is limited by the rapid emergence of resistance caused by mutations within the rifamycin-binding pocket. Rifamycin B (Rif B), one of the earliest discovered members of this antibiotic family and a precursor of clinically used derivatives, has remained poorly characterized because of its...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0de4d5f7-6285-5696-a552-2c52f57e874f
- DOI
- 10.64898/2026.07.13.738162
